9/15/2022 7:41:31 AM
Eloxx Pharma Says Phase 2 Study Of ELX-02 With Ivacaftor In Class 1 Cystic Fibrosis Fails To Meet Endpoints
11/17/2021 7:27:26 AM
Eloxx Pharma Reports Positive Topline Results From Monotherapy Arms Of Phase 2 Trial Of ELX-02 In Class 1 CF
4/1/2021 7:52:49 AM
Eloxx Pharmaceuticals Buys Zikani Therapeutics